Data / Form D filings / Inscripta, Inc.
Inscripta, Inc.: Form D filings
Inscripta, Inc., a biotechnology company in Pleasanton, CA, filed 15 Form D notices with the SEC between 2016 and 2023. The latest, on June 1, 2023, reports $1.9 million sold of a $1.9 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5720 Stoneridge Drive, Pleasanton, CA, 94588
- Phone
- (925) 694-0333
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1667561
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | New notice | $1,855,000 | $1,855,000 | 2 | Nov 24, 2021 | sec.gov | |
| Jan 18, 2023 | New notice | $27,791,098 | $27,791,098 | 5 | Dec 13, 2022 | sec.gov | |
| Jan 18, 2023 | New notice | $4,399,977 | $4,399,977 | 4 | Dec 12, 2022 | sec.gov | |
| Apr 14, 2021 | New notice | $149,999,970 | $149,999,970 | 32 | Mar 30, 2021 | sec.gov | |
| Nov 30, 2020 | New notice | $49,999,996 | $49,999,996 | 6 | Nov 13, 2020 | sec.gov | |
| Nov 30, 2020 | New notice | $8,060,048 | $8,060,048 | 1 | Oct 26, 2020 | sec.gov | |
| Dec 11, 2019 | New notice | $124,999,957 | $92,149,960 | $32,849,997 | 12 | Nov 27, 2019 | sec.gov |
| Apr 15, 2019 | Amendment | $49,999,979 | $49,999,979 | 14 | Jan 4, 2019 | sec.gov | |
| Jan 22, 2019 | New notice | $29,999,981 | $25,649,982 | $4,349,999 | 11 | Jan 4, 2019 | sec.gov |
| Sep 17, 2018 | New notice | $1,146,592 | $1,146,592 | 9 | Aug 31, 2018 | sec.gov | |
| Mar 7, 2018 | New notice | $55,499,974 | $55,499,974 | 14 | Feb 20, 2018 | sec.gov | |
| Mar 7, 2018 | New notice | $1,005,358 | $1,005,358 | 1 | Nov 23, 2016 | sec.gov | |
| Mar 1, 2017 | New notice | $22,999,995 | $22,999,995 | 10 | Feb 16, 2017 | sec.gov | |
| May 11, 2016 | New notice | $6,035,341 | $6,035,341 | 2 | Apr 29, 2016 | sec.gov | |
| May 11, 2016 | New notice | $3,000,000 | $3,000,000 | 2 | Feb 4, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Justin Ferber | Executive Officer | |
| John R. Stuelpnagel | Director | |
| Roger R. Wyse | Director | |
| Kristala L. Jones Prather | Director | |
| Sri Kosaraju | Executive Officer, Director | |
| Bryan L. Roberts | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 29, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inscripta, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.